Macaca < Macaca fascicularis < Macaca mulatta

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]

Ident.	Authors (with country if any)	Title
000279 (2000)	I. Ghorayeb [France] ; P O Fernagut ; I. Aubert ; E. Bezard ; Werner Poewe [Autriche] ; G K Wenning ; F. Tison	Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
000975 (2003)	Jay S. Schneider [États-Unis] ; Timothy V. Wade	Experimental parkinsonism is associated with increased pallidal GAD gene expression and is reversed by site-directed antisense gene therapy.
000B35 (1992)	B. Gomez-Mancilla [Canada] ; R. Boucher ; P J Bédard	Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
000B40 (1992)	B. Gomez-Mancilla [Canada] ; J F Latulippe ; R. Boucher ; P J Bédard	Effect of ethosuximide on rest tremor in the MPTP monkey model.
000C55 (2003)	Nancy Bélanger [Canada] ; Laurent Grégoire ; Abdallah Hadj Tahar ; Paul J. Bédard	Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys.
001277 (2005)	Pershia Samadi [Canada] ; Laurent Grégoire ; Arash Rassoulpour ; Paolo Guidetti ; Emanuela Izzo ; Robert Schwarcz ; Paul J. Bédard	Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys.
001377 (2005)	Pierre-Olivier Fernagut [États-Unis] ; Imad Ghorayeb ; Elsa Diguet ; François Tison	In vivo models of multiple system atrophy.
001421 (2006)	Marc Morissette [Canada] ; Mehdi Dridi ; Frédéric Calon ; Abdallah Hadj Tahar ; Leonard T. Meltzer ; Paul J. Bédard ; Thérèse Di Paolo	Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.
001D24 (1991)	T Z Aziz [Royaume-Uni] ; D. Peggs ; M A Sambrook ; A R Crossman	Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate.
002003 (2008)	Jose L. Lanciego [Espagne] ; Maria C. Rodríguez-Oroz [Espagne] ; Francisco J. Blesa [Espagne] ; Lydia Alvarez-Erviti [Espagne] ; Jorge Guridi [Espagne] ; Pedro Barroso-Chinea [Espagne] ; Yoland Smith [États-Unis] ; Jose A. Obeso [Espagne]	Lesion of the Centromedian Thalamic Nucleus in MPTP-Treated Monkeys
002720 (2009)	Glenda Halliday [Australie] ; Maria Trinidad Herrero ; Karen Murphy ; Heather Mccann ; Francisco Ros-Bernal ; Carlos Barcia ; Hideo Mori ; Francisco J. Blesa ; José A. Obeso	No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism.
002928 (2010)	Pershia Samadi [Canada] ; Marc Morissette ; Daniel Lévesque ; Thérèse Di Paolo	BDNF levels are not related with levodopa-induced dyskinesias in MPTP monkeys.
002B28 (2010)	Tom H. Johnston [Canada] ; Anne Van Der Meij ; Jonathan M. Brotchie ; Susan H. Fox	Effect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease.
002E52 (2010)	Tom H. Johnston [Canada] ; Susan H. Fox ; Matthew J. Piggott ; Juha-Matti Savola ; Jonathan M. Brotchie	The α₂ adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates.
003099 (2011)	James B. Koprich [Canada] ; Susan H. Fox ; Tom H. Johnston ; Allan Goodman ; Bertrand Le Bourdonnec ; Roland E. Dolle ; Robert N. Dehaven ; Diane L. Dehaven-Hudkins ; Patrick J. Little ; Jonathan M. Brotchie	The selective mu-opioid receptor antagonist ADL5510 reduces levodopa-induced dyskinesia without affecting antiparkinsonian action in MPTP-lesioned macaque model of Parkinson's disease.
003662 (1990)	N M Rupniak [Royaume-Uni] ; S J Tye ; M J Steventon ; S. Boyce ; S D Iversen	Spontaneous orofacial dyskinesias in a captive cynomolgus monkey: implications for tardive dyskinesia.
003794 (1990)	S. Boyce [Royaume-Uni] ; C E Clarke ; R. Luquin ; D. Peggs ; R G Robertson ; I J Mitchell ; M A Sambrook ; A R Crossman	Induction of chorea and dystonia in parkinsonian primates.
003798 (1990)	I J Mitchell [Royaume-Uni] ; R. Luquin ; S. Boyce ; C E Clarke ; R G Robertson ; M A Sambrook ; A R Crossman	Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia.
003926 (2013)	Jay S. Schneider [États-Unis] ; Elsa Y. Pioli ; Yang Jianzhong ; Qin Li ; Erwan Bezard	Levodopa improves motor deficits but can further disrupt cognition in a macaque Parkinson model.
003988 (2013)	Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo Carta	Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
003F38 (2014)	Wai Kin D. Ko [France] ; Elsa Pioli ; Qin Li ; Steve Mcguire ; Audrey Dufour ; Todd B. Sherer ; Erwan Bezard ; Maurizio F. Facheris	Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Macaca fascicularis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Macaca fascicularis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Macaca fascicularis
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024